BioLife Solutions (BLFS) Reports Prelim. 2Q Revenues Above Consensus; Boosts FY18 Revenue Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. MU
3. FDX
4. SPY
5. META
6. ABBV
7. NVDA
8. BLZE
9. IBM
10. NKE

Go back to BioLife Solutions (BLFS) Reports Prelim. 2Q Revenues Above Consensus; Boosts FY18 Revenue Guidance

BioLife Solutions (BLFS) PT Raised to $18 at Maxim Group as Cell Media Revs Beat Expecations

July 2, 2018 11:04 AM EDT

Maxim Group raised its price target on BioLife Solutions (NASDAQ: BLFS) to $18.00 (from $12.00) while maintaining a Buy rating.

Analyst Jason McCarthy highlighted:

BioLife shares are up today (15%+) following the company's announcement of preliminary cell preservation media revenue for 2Q18 coming in at $5.2M, up 36% sequentially and 103% y/y. The company raised guidance to $18.5M-$20M, from $14.5M-$15.5M. The company is... More